D. J. Richel

1.6k citations

29 papers · 844 indexed · h-index 17

Oncology top 10%
Surgery
Molecular Biology
Pulmonary and Respiratory Medicine top 10%
Hematology top 5%

Co-authors: Roel Willemze Jurriaan B. Tuynman G. J. A. Offerhaus Sjoerd M. Lagarde Maikel P. Peppelenbosch Hanneke C. Kluin‐Nelemans S. van der Vegt J. Jan B. van Lanschot
Topics: Esophageal Cancer Research and Treatment (7 papers)Inflammatory mediators and NSAID effects (5 papers)Acute Myeloid Leukemia Research (4 papers)
Cited by: Hematology Oncology Oral Surgery
Journals: Journal of Clinical Oncology British Journal of Cancer Annals of Oncology
Partner nations: Netherlands Switzerland Canada

In The Last Decade

D. J. Richel

28 papers receiving 822 citations

Peers

Countries citing papers authored by D. J. Richel

Since Specialization

Citations

This map shows the geographic impact of D. J. Richel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. J. Richel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. J. Richel more than expected).

Fields of papers citing papers by D. J. Richel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. J. Richel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. J. Richel. The network helps show where D. J. Richel may publish in the future.

Co-authorship network of co-authors of D. J. Richel

This figure shows the co-authorship network connecting the top 25 collaborators of D. J. Richel. A scholar is included among the top collaborators of D. J. Richel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. J. Richel. D. J. Richel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase I study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastasized pancreatic cancer 2017 ·Annals of Oncology ·(unknown),Remco J. Molenaar,Remy Klaassen,Maarten F. Bijlsma,Mariëtte J. Weterman,D. J. Richel,(unknown),Hanneke W.M. van Laarhoven,Johanna W. Wilmink	6
2	Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer 2011 ·European Journal of Surgical Oncology ·Mark van Heijl,Saffire S.K.S. Phoa,Mark I. van Berge Henegouwen,Jikke M.T. Omloo,Banafsche Mearadji,G. W. Sloof,Patrick M. Bossuyt,Maarten C.C.M. Hulshof,D. J. Richel,Jacques Bergman,F.J.W. ten Kate,Jaap Stoker,J. Jan B. van Lanschot	29
3	Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies 2008 ·Annals of Oncology ·Daniel Rayson,D. J. Richel,Stephen Chia,Christian Jackisch,S. van der Vegt,Thomas Suter	73
4	Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS) 2008 ·BMC Surgery ·Mark van Heijl,JJB van Lanschot,Linetta B. Koppert,Mark I. van Berge Henegouwen,Karin Müller,Ewout W. Steyerberg,Herman van Dekken,B.P.L. Wijnhoven,(unknown),D. J. Richel,O.R. Busch,(unknown),(unknown),G. J. A. Offerhaus,Ate van der Gaast	99
5	Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade 2008 ·Annals of the Rheumatic Diseases ·Tineke Cantaert,L De Rycke,Clio P. Mavragani,Carla A. Wijbrandts,Timothy B. Niewold,Tatjana M.H. Niers,Bernard Vandooren,Eric Veys,D. J. Richel,Paul P. Tak,Mary K. Crow,Dominique Baeten	21
6	Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma 2008 ·British Journal of Cancer ·Jurriaan B. Tuynman,Sjoerd M. Lagarde,F. J. W. Ten Kate,D. J. Richel,J. Jan B. van Lanschot	44
7	Molecular Prognostic Factors in Adenocarcinoma of the Esophagus and Gastroesophageal Junction 2006 ·Annals of Surgical Oncology ·Sjoerd M. Lagarde,F.J.W. ten Kate,D. J. Richel,G. J. A. Offerhaus,J. Jan B. van Lanschot	51
8	Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: a report of 2 cases 2006 ·International Journal of Oral and Maxillofacial Surgery ·Jan de Lange,Hans P. van den Akker,Henk van den Berg,D. J. Richel,Richmond A. Th. Gortzak	51
9	Altered bone morphogenetic protein signalling in the Helicobacter pylori‐infected stomach 2006 ·The Journal of Pathology ·(unknown),Liudmila L. Kodach,María Jesús García-León,D. J. Richel,Maikel P. Peppelenbosch,PH Reitsma,James C.H. Hardwick,(unknown)	37
10	Short intensive chemoradiation, 50 Gy/4 weeks with tegafur/uracil, leucovorin and celecoxib for non-metastatic locally advanced pancreatic cancer 2005 ·Journal of Clinical Oncology ·Walter L. Vervenne,Marco J. Bruno,D. J. Gouma,Saffire S.K.S. Phoa,D. J. Richel,Geertjan van Tienhoven	1
11	COX-2 inhibition as a tool to treat and prevent colorectal cancer 2004 ·Critical Reviews in Oncology/Hematology ·Jurriaan B. Tuynman,Maikel P. Peppelenbosch,D. J. Richel	44
12	Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma 2003 ·Scandinavian Journal of Gastroenterology ·Christianne J. Buskens,(unknown),G. J. A. Offerhaus,D. J. Richel,J.J.B. van Lanschot	27
13	Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer 1993 ·Annals of Oncology ·Elsken van der Wall,D. J. Richel,Yoka H. Kusumanto,Emiel J. Rutgers,Jan H. Schornagel,C. Schaake-Koning,J.L. Peterse,Sjoerd Rodenhuis	16
14	Increase in Ara-C sensitivity in Ara-C sensitive and -resistant leukemia by stimulation of the salvage and inhibition of the de novo pathway 1992 ·Annals of Hematology ·L. P. Colly,D. J. Richel,(unknown),(unknown),(unknown),Roel Willemze	12
15	The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia 1991 ·British Journal of Cancer ·D. J. Richel,(unknown),Hanneke C. Kluin‐Nelemans,Roel Willemze	56
16	Deoxycytidine kinase, thymidine kinase and cytidine deaminase and the formation of ARA-CTP in leukemic cells in different phases of the cell cycle 1990 ·Leukemia Research ·D. J. Richel,L. P. Colly,(unknown),(unknown),Roel Willemze	13
17	SEROLOGICAL AND MOLECULAR STUDIES OF EPSTEIN-BARR VIRUS INFECTION IN ALLOGENEIC MARROW GRAFT RECIPIENTS 1990 ·Transplantation ·Jan W. Gratama,M. A. P. Oosterveer,(unknown),J. J. van Rood,F. E. Zwaan,J M Vossen,Jacoba G. Kapsenberg,D. J. Richel,Georg Klein,Ingemar Ernberg	31
18	Epstein-Barr virus in a CD8-positive T-cell lymphoma. 1990 ·PubMed ·D. J. Richel,(unknown),Jacoba G. Kapsenberg,E. C. M. Ooms,(unknown),Charles A. Boucher,P. M. Kluin	48
19	Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia 1988 ·British Journal of Cancer ·D. J. Richel,(unknown),(unknown),Roel Willemze	20
20	Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia. 1987 ·PubMed ·(unknown),(unknown),D. J. Richel,(unknown),(unknown),R. Willemze	39

About D. J. Richel

D. J. Richel is a scholar working on Hematology, Oncology and Pharmacology, having authored 29 papers that have together received 844 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Acute Myeloid Leukemia Research (4 papers). The work is most often cited by research in Hematology (161 citations), Oncology (313 citations) and Oral Surgery (48 citations). D. J. Richel has collaborated with scholars based in Netherlands, Switzerland and Canada. Frequent co-authors include Roel Willemze, Jurriaan B. Tuynman, G. J. A. Offerhaus, Sjoerd M. Lagarde, Maikel P. Peppelenbosch, Hanneke C. Kluin‐Nelemans, S. van der Vegt, J. Jan B. van Lanschot, Daniel Rayson and Stephen Chia. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact